|
Bextra RecallBextra, a COX-2 inhibiting non-steroidal anti-inflammatory drug (NSAID), was introduced by Pfizer to the US drug market in November 2001 to treat the severe pain associated with osteoarthritis, rheumatoid arthritis and menstrual cramps. Bextra, and other drugs of its class, have come under scrutiny for their potential to cause severe side effects. New scientific developments are revealing that some of these COX-2 selective NSAIDs like Bextra double a patient's risk of suffering heart problems and strokes. A Bextra lawsuit is a civil action that can be brought against the manufacturers by patients who have suffered harmful side effects as a result of taking this prescription drug. Severe side effects involved in a Bextra lawsuit include heart attacks, stroke, Stevens-Johnson syndrome, and death. Bextra has been proven to cause acute allergic reactions and skin diseases in some patients. In rare cases, taking Bextra causes fatal skin reactions such as Toxic Epidermal Necrolysis and Stevens-Johnson syndrome. Pfizer said that because of these new findings, they will add a black box warning to the Bextra labeling, warning patients of these serious potential side effects. In a preliminary study, presented at the American Heart Association meeting on November 9, 2004, it was revealed that Bextra may cause an increased risk of heart attack and stroke in patients. Pfizer claims that these findings are unsupported. Plans are underway to study the effects of Bextra and other COX-2 inhibitors on cardiovascular health by Pfizer and the FDA. If you have suffered harmful side effects as a result of taking Bextra, contact us today to put you in touch with experienced and knowledgeable attorneys who can determine your eligibility in a Bextra lawsuit.
|
Select a State. Make Contact. Make the Decision. |
